Plus Therapeutics, Inc.

Plus Therapeutics, Inc.

PSTV
Plus Therapeutics, Inc.US flagNASDAQ Capital Market
4.05
USD
+0.07
- -
9.80MMarket Cap

Income Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
10
15
12
8
12
11
6
3
7
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
10
15
12
8
12
11
6
3
7
- -
- -
- -
- -
- -
- -
- Cost of Revenue
4
4
3
3
3
2
1
1
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
4
4
3
3
3
2
1
1
- -
- -
- -
- -
- -
- -
- -
Gross Profit
6
11
9
5
8
9
5
6
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
3
-7
- -
- -
- -
- -
- -
- -
- Operating Expenses
39
39
42
37
31
29
26
12
11
10
12
20
13
15
15
+ Selling, General & Admin
28
25
25
22
12
12
11
6
5
6
7
10
9
10
12
+ Research & Development
11
14
17
15
19
16
13
6
5
3
6
10
10
11
8
+ Other Operating Expense
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
-5
-6
-5
Operating Income (Loss)
-33
-28
-33
-33
-23
-20
-21
-9
-4
-10
-12
-20
-13
-15
-15
- Non-Operating (Income) Loss
-1
4
-7
5
-4
2
2
- -
- -
-1
1
1
- -
-2
7
+ Interest Expense, Net
3
3
3
4
3
3
2
2
2
1
1
1
- -
3
3
+ Interest Expense
3
3
3
4
3
3
2
2
2
1
1
1
- -
4
4
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-3
1
-11
- -
-8
- -
- -
-2
-2
-2
- -
- -
- -
-5
4
Pretax Income
-32
-32
-26
-37
-19
-22
-23
-9
-3
-8
-13
-20
-13
-13
-22
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-32
-32
-26
-37
-19
-22
-23
-9
-3
-8
-13
-20
-13
-13
-22
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
4
8
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
-4
-8
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
8
15
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-32
-32
-26
-37
-19
-22
-23
-13
-11
-8
-13
-20
-13
-13
-22
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-32
-32
-26
-37
-19
-22
-23
-13
-11
-8
-13
-20
-13
-13
-22
- Preferred Dividends
- -
- -
- -
1
1
- -
4
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-32
-32
-26
-39
-19
-22
-27
-13
-11
-8
-13
-20
-13
-13
-22
EBIT
-33
-28
-33
-33
-23
-20
-21
-9
-4
-10
-12
-20
-13
-15
-15
EBITDA
-32
-27
-32
-32
-22
-19
-19
-7
-3
-9
-12
-19
-13
-14
-15
EBITDA Margin (%)
-321.9
-188.64
-260.06
-421.52
-187.5
-162.78
-289.07
-226.55
-39.45
-3,042.24
- -
- -
- -
- -
- -
EBITA
-33
-28
-33
-33
-23
-20
-21
-9
-4
-10
-12
-20
-13
-15
-15
Gross Margin (%)
61.61
72.42
71.95
61.31
72.67
80.93
79.44
61.52
100
100
- -
- -
- -
- -
- -
Operating Margin (%)
-330.45
-195.07
-273.43
-431.77
-196.88
-173.16
-322.62
-293.73
-52.26
-3,163.04
- -
- -
- -
- -
- -
Profit Margin (%)
-324.64
-222.6
-214.64
-491.81
-160.77
-193.73
-353.86
-423.53
-155.57
-2,719.8
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
1,041.67
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
1
1
2
1
1
1
2
2
1
- -
- -
1
1
1
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
Basic EPS, GAAP
-1,545,285.71
-1,344,958.33
-1,006,807.69
-1,041,540.54
-269,513.89
-191,704.35
-86,568.18
-15,992.41
-2,950.41
-697.98
-415.64
-289.58
-105.99
-48.86
-7.19
Basic EPS from Cont Ops
-1,545,285.71
-1,344,958.33
-1,006,807.69
-1,009,945.95
-260,333.33
-191,704.35
-73,655.84
-11,237.97
-889.7
-697.98
-415.64
-289.58
-105.99
-48.86
-7.19
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
Diluted EPS, GAAP
-1,545,285.71
-1,344,958.33
-1,006,807.69
-1,041,540.54
-269,513.89
-191,704.35
-86,568.18
-15,992.41
-2,950.41
-697.98
-415.64
-289.58
-105.99
-42.13
-7.19
Diluted EPS from Cont Ops
-1,545,285.71
-1,344,958.33
-1,006,807.69
-1,009,945.95
-260,333.33
-191,704.35
-73,655.84
-11,237.97
-889.7
-697.98
-415.64
-289.58
-105.99
-42.13
-7.19

Balance Sheet (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
43
34
25
22
21
19
15
10
20
9
20
22
10
5
15
+ Cash, Cash Equivalents & STI
37
26
16
15
14
13
10
5
18
8
18
18
9
4
9
+ Cash & Cash Equivalents
37
26
16
15
14
13
10
5
18
8
18
18
9
- -
4
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
+ Accounts & Notes Receiv
2
4
4
1
1
1
- -
- -
1
- -
- -
- -
- -
1
- -
+ Accounts Receivable, Net
2
4
4
1
1
1
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Inventories
3
3
4
5
4
4
3
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
2
1
1
2
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
1
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
1
1
2
2
2
2
2
2
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
1
1
1
1
2
4
1
1
1
4
1
1
6
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
8
9
17
17
16
16
17
14
3
3
2
2
2
1
1
+ Property, Plant & Equip, Net
2
2
1
2
2
1
3
2
3
2
2
2
1
1
- -
+ Property, Plant & Equip
10
11
11
11
11
10
11
3
4
4
3
4
4
4
4
- Accumulated Depreciation
8
9
10
9
9
8
8
1
1
1
1
2
3
3
3
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
6
7
16
15
15
15
14
12
- -
- -
- -
- -
- -
1
1
+ Total Intangible Assets
4
4
13
13
13
12
11
- -
- -
- -
- -
- -
- -
1
1
+ Goodwill
4
4
4
4
4
4
4
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
9
9
9
8
7
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
2
3
3
2
2
2
3
12
- -
- -
- -
- -
- -
- -
- -
Total Assets
52
43
42
39
38
35
32
24
23
12
22
24
11
7
16
+ Payables & Accruals
5
7
6
5
6
6
5
2
3
2
4
10
6
11
5
+ Accounts Payable
- -
2
1
1
1
1
1
1
- -
1
3
8
5
9
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
5
6
5
4
5
4
3
2
3
1
1
1
2
1
2
+ ST Debt
2
10
3
7
2
7
14
14
11
6
2
2
4
3
1
+ ST Borrowings
2
10
3
7
2
7
14
14
11
6
2
2
4
3
1
+ ST Finance Leases
- -
10
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
6
3
- -
- -
- -
1
- -
- -
- -
- -
- -
1
6
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
6
3
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
5
Total Current Liabilities
8
18
15
16
8
13
18
18
14
9
6
12
11
16
12
+ LT Debt
22
13
23
18
17
11
- -
- -
1
1
5
4
- -
- -
- -
+ LT Borrowings
22
13
23
18
17
11
- -
- -
- -
- -
5
4
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
+ Other LT Liabilities
12
6
1
10
- -
- -
- -
1
7
- -
- -
2
2
- -
- -
+ Accrued Liabilities
9
4
1
1
- -
- -
- -
- -
- -
- -
- -
2
2
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
3
2
- -
10
- -
- -
- -
1
7
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
34
19
24
29
17
11
- -
1
8
1
5
6
2
- -
- -
Total Liabilities
42
37
39
44
25
24
19
19
22
9
11
17
13
16
12
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
252
281
304
332
368
389
413
418
426
437
458
474
479
485
520
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
252
281
304
332
368
389
413
418
426
437
458
474
479
485
520
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-242
-275
-301
-338
-357
-379
-402
-414
-425
-434
-447
-467
-481
-493
-516
+ Other Equity
- -
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
10
6
3
-6
12
11
13
5
1
3
11
6
-1
-9
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
10
6
3
-6
12
11
13
5
1
3
11
6
-1
-9
4
Total Liabilities & Equity
52
43
42
39
38
35
32
24
23
12
22
24
11
7
16
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
10
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
Net Debt
-12
-3
11
11
4
5
4
9
-6
-2
-12
-13
-5
3
-4
Net Debt to Equity
-125.41
-46.94
344.35
-189.09
33.53
46.21
31.34
171.12
-559.66
-66.35
-108.78
-197.46
339.61
-35.94
-87.74
Tangible Common Equity Ratio
12.3
6.44
-35.2
-75.01
-3.02
-6.22
9.13
20.55
3.45
22.09
48.3
25.55
-16.06
-169.03
21.07
Current Ratio
5.54
1.93
1.65
1.36
2.52
1.5
0.81
0.55
1.37
1.07
3.36
1.84
0.92
0.34
1.23
Cash Conversion Cycle
384.45
286.51
369.48
572.93
424.15
444.01
377.73
733.8
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2011
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-32
-32
-26
-37
-19
-22
-23
-13
-11
-8
-13
-20
-13
-13
-22
+ Depreciation & Amortization
1
1
2
1
1
1
2
2
1
- -
- -
1
1
1
- -
+ Non-Cash Items
1
5
-5
6
-4
2
3
- -
5
-1
1
1
1
-2
7
+ Stock-Based Compensation
3
4
4
3
2
1
1
- -
- -
- -
1
1
1
1
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-2
1
-9
3
-6
1
3
-1
5
-1
1
- -
- -
-2
6
+ Chg in Non-Cash Work Cap
-5
-6
-5
- -
1
-1
-1
-1
-1
- -
1
6
-1
3
-6
+ (Inc) Dec in Accts Receiv
-1
-2
-1
2
- -
- -
1
- -
-1
1
- -
- -
- -
-1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
-1
1
- -
-1
1
-1
-2
-2
- -
-1
2
6
-4
5
-6
+ Inc (Dec) in Other
-3
-6
-3
- -
-1
- -
-1
- -
- -
- -
- -
-1
3
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-35
-32
-35
-30
-20
-20
-18
-12
-6
-8
-10
-13
-13
-11
-21
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
-1
-1
-1
- -
-1
- -
- -
- -
- -
-1
- -
-1
- -
+ Acq of Fixed Prod Assets
-1
-1
-1
-1
-1
- -
-1
- -
- -
- -
- -
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
- -
+ Cash (Repurchase) of Equity
13
25
18
19
29
21
22
6
16
4
19
16
5
7
39
+ Increase in Capital Stock
13
25
18
19
29
21
24
7
16
4
19
16
6
7
39
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
-2
-2
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3
-1
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
12
9
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-16
-9
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
6
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
6
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
5
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-1
4
-1
-1
- -
-1
- -
6
- -
- -
-1
- -
-4
-1
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
5
-3
5
-2
-7
- -
-5
- -
-4
-5
- -
-2
-2
-1
-3
+ Cash From Debt
9
- -
27
- -
18
- -
- -
- -
- -
- -
- -
- -
- -
3
4
+ Repayments of Debt
-5
-3
-22
-2
-25
- -
-5
- -
-4
-5
- -
-2
-2
-4
-7
+ Other Financing Activities
2
- -
-2
14
-1
-4
- -
1
- -
1
2
-1
- -
- -
-6
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
20
22
21
31
21
18
17
7
13
- -
20
13
3
6
30
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-16
-11
-10
-1
- -
-2
-3
-5
12
-9
10
- -
-10
-8
9
EBITDA
-32
-27
-32
-32
-22
-19
-19
-7
-3
-9
-12
-19
-13
-14
-15
EBITDA Margin (%)
-321.9
-188.64
-260.06
-421.52
-187.5
-162.78
-289.07
-226.55
-39.45
-3,042.24
- -
- -
- -
- -
- -
Free Cash Flow
-36
-33
-36
-31
-21
-20
-20
-12
-6
-9
-10
-14
-13
-11
-21
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
-6
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
-31
-36
-30
-34
-29
-20
-28
-12
-10
-14
-11
-15
-15
-11
-23
Free Cash Flow per Basic Share
-1,708,714.29
-1,391,541.67
-1,380,076.92
-847,270.27
-292,944.44
-170,434.78
-63,714.29
-15,326.58
-1,618.7
-756.08
-323.36
-196.12
-103.56
-42.34
-6.7
Price/Free Cash Flow
-3.74
-6.1
-5.65
-1.74
-1.94
-1.67
-1.04
-0.36
-0.57
-1.13
-1.25
-0.69
-0.43
-0.9
-1.93
Cash Flow to Net Income
1.09
1
1.32
0.81
1.09
0.89
0.8
0.95
0.54
1.02
0.77
0.64
0.97
0.81
0.93
Capital Expenditures
-1
-1
-1
-1
-1
- -
-1
- -
- -
- -
- -
-1
- -
-1
- -